… .A. (NASDAQ:EDAP) Q4 2024 Earnings Call Transcript March 27, 2025 … EDAP TMS S.A. beats earnings expectations. Reported EPS is $-0 … Quarter and Full Year 2024 Earnings Conference Call. At this time … 60 consecutive patients from the Endo-HIFU-R1 Phase 2 study …

… Eton Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS … statements disclaimer in our earnings release and the risk … conferences. With PES, PENDS, ENDO, NAAP. Peer-to-peer … reporting adjusted non-GAAP earnings results. This is intended …

… Month, we have launched the Endo the Battle campaign, to … experienced a significant decrease in earnings, which makes funding private care … but also the loss of earnings. I had my own business … Dometriosis, as well as founding Endo Education. When asked what …

Deals: Mallinckrodt and Endo are merging in a deal … its experimental treatment for obesity.  Endo sold its international pharmaceuticals business … announcement of diminished Q4 2024 earnings. It projects lower revenue in …

… , National World is launching the Endo The Battle campaign to amplify … experienced a significant decrease in earnings, which makes seeking and funding …

… troubled drugmakers Mallinckrodt and Endo have decided to join … billion in 2025 revenue, plus earnings of $1.2 billion. … combination of Mallinckrodt and Endo brings together two essential … branded businesses, Mallinckrodt and Endo ultimately aim to combine …

… pro forma 2025 adjusted earnings before interest, taxes, … other areas.” The Mallinckrodt-Endo combination will have approximately … combination of Mallinckrodt and Endo brings together two essential … pursue growth opportunities. Endo and Mallinckrodt both have …

… fourth quarter and fiscal year earnings calls, each of which … of the website. About Endo Endo is a diversified pharmaceutical company … between Mallinckrodt and Endo, Mallinckrodt and Endo's plans … businesses of Mallinckrodt and Endo and Endo's sterile …

… Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $- … Inc. fourth quarter 2024 Earnings Conference Call. I would now … reporting Q4 results. The earnings press release and presentation are … address those issues with Endo and that they can’ …

… Full Year 2024 Ascendis Pharma Earnings Conference Call. At this time … that is in seeing an endo. So often that perspective, just … , when you can see an endo, we actually believe that many … part because they see the endo in a much higher frequency …